PDS Biotechnology (PDSB) Times Interest Earned (2014 - 2026)
PDS Biotechnology's (PDSB) quarterly Times Interest Earned came in at -$2.19 in Q4 2025, down 100.62% YoY from $354.08 in Q4 2024, and up 69.11% on a QoQ basis from -$7.08 in Q3 2025.
PDS Biotechnology (PDSB) Times Interest Earned (2014 - 2026) Analysis & Trends
PDS Biotechnology (PDSB) has 12 years of Times Interest Earned data on file, last reported at -$2.19 in Q4 2025.
- Quarterly Times Interest Earned fell 100.62% year-over-year to -$2.19 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$4.33 (up 58.05% YoY) and the FY2025 annual result came in at -$0.43, up 23.44% from the prior year.
- Times Interest Earned advanced to -$2.19 in Q4 2025, from -$7.08 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of $354.08 in Q4 2024 to a low of -$146.9 in Q4 2021.
- A 5-year average of $4.28 and a median of -$4.14 in 2024 frame the typical range for Times Interest Earned.
- Annual changes were most pronounced in 2022 — Times Interest Earned plunged 2663.64% — and 2024, when it soared 4097.02%.
- Tracing PDSB's Times Interest Earned over 5 years: stood at -$146.9 in 2021, then soared by 71.83% to -$41.38 in 2022, then surged by 78.59% to -$8.86 in 2023, then soared by 4097.02% to $354.08 in 2024, then sank by 100.62% to -$2.19 in 2025.
- The last three Times Interest Earned figures came in at -$2.19 (Q4 2025), -$7.08 (Q3 2025), and -$3.55 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | PDS Biotechnology | 12.02 Mn | 12.02 Mn | - | -1.92 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.92 |
| Dec 31, 2025 | -2.19 |
| Sep 30, 2025 | -7.08 |
| Jun 30, 2025 | -3.55 |
| Mar 31, 2025 | -9.78 |
| Dec 31, 2024 | 354.08 |
| Sep 30, 2024 | -4.72 |
| Jun 30, 2024 | -7.31 |
| Mar 31, 2024 | -8.60 |
| Dec 31, 2023 | -8.86 |
| Sep 30, 2023 | -2.25 |
| Jun 30, 2023 | -2.73 |
| Mar 31, 2023 | -9.75 |
| Dec 31, 2022 | -41.38 |
| Sep 30, 2022 | -6.47 |
| Jun 30, 2022 | -3.28 |
| Mar 31, 2022 | -1.32 |
| Dec 31, 2021 | -146.90 |
| Sep 30, 2021 | -0.23 |
| Jun 30, 2021 | -0.20 |